These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2029808)

  • 1. Pharmacodynamic modelling. Application to new drug development.
    Kroboth PD; Schmith VD; Smith RB
    Clin Pharmacokinet; 1991 Feb; 20(2):91-8. PubMed ID: 2029808
    [No Abstract]   [Full Text] [Related]  

  • 2. [Continuing education. Clinical trials].
    Sökeland J
    Urologe A; 1990 Nov; 29(6):W41-2. PubMed ID: 2291253
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical drug trials. 1: The 4 phases of clinical trials].
    Gleiter CH; Bieck PR
    Fortschr Med; 1991 Feb; 109(5):136-7. PubMed ID: 2045036
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacodynamic analysis of sparse data from concentration- and effect-controlled clinical trials guided by a pilot study. An investigation by simulations.
    Fullerton T; Forrest A; Levy G
    J Pharm Sci; 1996 Jun; 85(6):600-7. PubMed ID: 8773956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodology of clinical trials on new drugs in epilepsy.
    Morselli PL
    Funct Neurol; 1986; 1(4):503-11. PubMed ID: 3609878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Foundations of pharmacotherapy. Clinical pharmacology in key words. Drug testing II].
    MMW Munch Med Wochenschr; 1979 Nov; 121(46):46-8. PubMed ID: 117346
    [No Abstract]   [Full Text] [Related]  

  • 8. Multivariate estimation of the relative dose potency.
    Källén A
    Stat Med; 2004 Jul; 23(14):2187-93. PubMed ID: 15236424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of an alternative approach to dose-response trials.
    Sheiner LB
    J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 2():S20-6. PubMed ID: 2231298
    [No Abstract]   [Full Text] [Related]  

  • 10. What in vitro models of infection can and cannot do.
    White RL
    Pharmacotherapy; 2001 Nov; 21(11 Pt 2):292S-301S. PubMed ID: 11714221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of new drugs].
    Lewis PJ
    Rev Prat; 1982 Sep; 32(41-42):2649-50 passim. PubMed ID: 7146802
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of anticancer medicinal products in man. CPMP Working Party on Efficacy of Medicinal Products.
    Pharmacol Toxicol; 1990 Nov; 67(5):454-8. PubMed ID: 2096391
    [No Abstract]   [Full Text] [Related]  

  • 13. In silico prediction of clinical efficacy.
    Michelson S; Sehgal A; Friedrich C
    Curr Opin Biotechnol; 2006 Dec; 17(6):666-70. PubMed ID: 17046236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for the evaluation of dose-toxicity relationships in clinical trials.
    Mather FJ; Simon RM; Clark GM; Von Hoff DD
    Stat Med; 1989 Jul; 8(7):813-23. PubMed ID: 2772441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development. The "wooden shoe' paradigm.
    Breimer DD; Danhof M
    Clin Pharmacokinet; 1997 Apr; 32(4):259-67. PubMed ID: 9113436
    [No Abstract]   [Full Text] [Related]  

  • 16. A consideration of the guidelines for investigating potential new drugs in humans in the United Kingdom.
    McGillion FB
    Methods Find Exp Clin Pharmacol; 1979 Apr; 1(1):45-50. PubMed ID: 552581
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of drugs].
    Wasielewski S
    Med Monatsschr Pharm; 1992 Feb; 15(2):34. PubMed ID: 1579074
    [No Abstract]   [Full Text] [Related]  

  • 18. The conduct of phase I-II clinical trials in children with cancer.
    Pratt CB
    Med Pediatr Oncol; 1991; 19(4):304-9. PubMed ID: 2056975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Journal club 101 for the new practitioner: evaluation of a clinical trial.
    Askew JP
    Am J Health Syst Pharm; 2004 Sep; 61(18):1885-7. PubMed ID: 15487877
    [No Abstract]   [Full Text] [Related]  

  • 20. [General modality for evaluation of drugs in pediatry].
    Autret E
    Arch Fr Pediatr; 1990 Nov; 47(9):627-8. PubMed ID: 2078119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.